dr. petrylak discusses psma-directed therapies in prostate cancer
Published 10 years ago • 323 plays • Length 1:55Download video MP4
Download video MP3
Similar videos
-
2:37
dr. daniel petrylak discusses novel bone targeted therapies in prostate cancer
-
1:05
dr. petrylak on psma adc for patients with mcrpc
-
1:23
dr. petrylak on a phase ii trial of psma adc in taxane-treated mcrpc
-
0:50
psma adc for prostate cancer
-
1:11
dr. petrylak on sequencing agents in prostate cancer
-
0:34
dr. petrylak discusses custirsen as a potential treatment for prostate cancer
-
1:10
dr. daniel petrylak discusses chemotherapy in prostate cancer
-
1:43
dr. petrylak on imaging approaches in prostate cancer
-
1:21
dr. petrylak explains prostate cancer clinical trial difficulties
-
1:43
dr. petrylak discusses sequencing prostate cancer therapies
-
0:47
dr. daniel petrylak describes the clinical investigation of prostvac in prostate cancer
-
2:05
dr. petrylak on imaging approaches in prostate cancer
-
1:19
dr. daniel petrylak on biomarker discovery in advanced prostate cancer
-
1:01
dr. petrylak on novel imaging modalities in prostate cancer
-
9:31
promising agents for the treatment of prostate cancer
-
0:47
dr. petrylak on the recent developments in prostate cancer
-
1:47
dr. petrylak on sequencing of targeted agents in bladder cancer
-
1:08
dr. daniel petrylak explains the correlation between immune response to sipuleucel-t and survival
-
1:03
dr. daniel petrylak on the role of enzalutamide in prostate cancer